Growth restriction: Etiology, maternal and neonatal outcome. A review

Current Women's Health Reviews

Volumn 3, Issue 3, 2007, Pages 145-160

  Haram, Kjell ^a   Svendsen, Einar ^b   Myking, Ole ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Etiology; Intrauterine growth restriction; Maternal and neonatal outcome; Small for gestational age

Indexed keywords

ACTIVIN A; ANTICONVULSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FERRITIN; HEMOGLOBIN; S FERRITIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; WARFARIN;

ALCOHOL CONSUMPTION; ANOREXIA NERVOSA; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CHROMOSOME DELETION; CONNECTIVE TISSUE DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ABUSE; DYSMATURITY; GENETIC DISORDER; GESTATIONAL AGE; HELICOBACTER INFECTION; HEREDITY; HOMEOSTASIS; HUMAN; HYPERTENSION; INTELLIGENCE QUOTIENT; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; LIPID METABOLISM; LOW BIRTH WEIGHT; MENTAL DISEASE; NEWBORN DEATH; NUTRITIONAL DEFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PERINATAL MORBIDITY; PERINATAL MORTALITY; PHYSICAL DISABILITY; PREECLAMPSIA; PREGNANCY OUTCOME; PRENATAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; RHEUMATIC DISEASE; RISK FACTOR; SCORING SYSTEM; SMOKING; SOCIAL ASPECT; TWIN TWIN TRANSFUSION SYNDROME; WORK ENVIRONMENT;

EID: 34548336362     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340407781387690     Document Type: Review

References (241)

1. Chard T, Yoong A, Macintosh M. The myth of fetal growth retardation at term. Br J Obstet Gynaecol 1993; 100: 1076-81.
2. Holmes RP, Soothill PW. Intra-uterine growth retardation. Curr Opin Obstet Gynecol 1996; 8: 148-54.
3. Robinson JS. Fetal growth. In: Turnbull A, Chamberlain G, Eds. Obstetrics. Edinburgh: Churchill Livingstone; 1989; pp. 141-50.
4. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002; 99: 490-6.
5. Lin CC, Santolaya-Forgas J. Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology. Obstet Gynecol 1998; 92: 1044-55.
6. Tan, T. Y. T. and Yeo, G. S. H. Intrauterine growth restriction. Curr Opin Obstet Gynecol 2005; 17: 135-42.
7. Goldenberg RL, Cliver SP. Small for gestational age and intrauterine growth restriction: definitions and standard. Clin Obstet Gynecol 1997; 40: 704-14.
8. Peleg D, Kennedy CM, Hunter SK. Intrauterine growth restriction: identification and management. Am Fam Physician 1998; 58: 453-7.
9. Seeds JW, Peng T. Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 1998; 178: 658-69.
10. Pollack RN, Divon MY. Intrauterine growth retardation: definition, classification, and etiology. Clin Obstet Gynecol 1992; 35: 99-107.
11. Maršál K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimalted foetal weights. Acta Paediatr 1996; 85: 843-8.
12. Sasanow SR, Georgieff MK, Pereira GR. Mid-arm circumference and mid-arm/ head cirumference ratios: standard curves for anthropometric assessment of neonatal nutritional status. J Pediatr. 1086; 109: 311-5.
13. Mongelli M, Gardosi J. Reduction of false-positive diagnosis of fetal growth restriction by application of customized fetal growth standards. Obstet Gynecol 1996; 88: 844-8.
14. Roemer VM, Kieback DG, Buhler K, Kohling U. Gestational age and birth weight. 3. Ponderal Index, fetal acid-base metabolism and hypotrophy. Z Geburtshilfe Perinatol 1991; 195: 239-49.
15. Soothill PW, Bobrow CS, Holmes R. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol 1999; 13: 225-8.
16. Seeds JW. Impaired fetal growth: ultrasonic evaluation and clinical management. Obstet Gynecol 1984; 64: 577-84.
17. Monk D, Moore GE. Intrauterine growth restriction-genetic causes and consequences. Semin Fetal Neonatal Med 2004; 9: 371-8.
18. Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 2004; 19: 307-19.
19. Vandenbosche RC, Kirchner JT. Intrauterine growth retardation. Am Fam Physician 1998; 58: 1384-90.
20. Geirsson RT. Ultrasound instead of last menstrual period as the basis of gestational age assignment. Ultrasound Obstet Gynecol 1991; 1: 212-9.
21. Geirsson RT. Ultrasound: the rational way to determine gestational age. Fetal Matern Med Rev 1997; 9: 133-46.
22. Mul T, Mongelli M, Gardosi J. A comparative analysis of second-trimester ultrasound dating formulae in pregnancies conceived with artificial reproductive techniques. Ultrasound Obstet Gynecol 1996; 8: 397-402.
23. Wilcox M, Gardosi J, Mongelli M, Ray C, Johnson I. Birth weight from pregnancies dated by ultrasonography in a multicultural British population. BMJ 1993; 307: 588-91.
24. Skjærven R, Gjessing HK, Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 2000; 79: 440-9.
25. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108: E35.
26. Grundy MF, Hood J, Newman GB. Birth weight standards in a community of mixed racial origin. Br J Obstet Gynaecol 1978; 85: 481-6.
27. McFadyen IR, Campbell-Brown M, Abraham R, North WR, Haines AP. Factors affecting birthweights in Hindus, Moslems and Europeans. Br J Obstet Gynaecol 1984; 91: 968-72.
28. Thomson AM, Billewicz WZ, Hytten FE. The assessment of fetal growth. J Obstet Gynaecol Br Commonw 1968; 75: 903-16.
29. Tuck SM, Cardozo LD, Studd JW, Gibb DM, Cooper DJ. Obstetric characteristics in different racial groups. Br J Obstet Gynaecol 1983; 90: 892-7.
30. Prentice AM, Goldberg GR. Energy adaptations in human pregnancy: limits and long-term consequences. Am J Clin Nutr 2000; 71: 1226S-32S.
31. Bispham J, Gopalakrishnan GS, Dandrea J, et al. Maternal endocrine adaptation throughout pregnancy to nutritional manipulation: consequences for maternal plasma leptin and cortisol and the programming of fetal adipose tissue development. Endocrinology 2003; 144: 3575-85.
32. Wadhwa PD, Garite TJ, Porto M, et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 2004; 191: 1063-9.
33. Economides DL, Proudler A, Nicolaides KH. Plasma insulin in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol 1989; 160: 1091-4.
34. Langer O, Damus K, Maiman M, Divon M, Levy J, Bauman W. A link between relative hypoglycemia-hypoinsulinemia during oral glucose tolerance tests and intrauterine growth retardation. Am J Obstet Gynecol 1986; 155: 711-6.
35. Reis FM, D'Antona D, Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 2002; 23: 230-57.
36. Henson MC, Swan KF, O'Neil JS. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet Gynecol 1998; 92: 1020-8.
37. Henson MC, Castracane VD. Leptin in pregnancy. Biol Reprod 2000; 63: 1219-28.
38. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998; 18: 399-419.
39. Hardie LJ, Guilhot N, Trayhurn P. Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res 1996; 28: 685-9.
40. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000; 143: 293-311.
41. Linnemann K, Malek A, Schneider H, Fusch C. Physiological and pathological regulation of feto/placento/maternal leptin expression. Biochem Soc Trans 2001; 29: 86-90.
42. Symonds ME, Mostyn A, Stephenson T. Cytokines and cytokine receptors in fetal growth and development. Biochem Soc Trans 2001; 29: 33-7.
43. Hytinantti T, Koistinen HA, Koivisto VA, Karonen SL, Rutanen EM, Andersson S. Increased leptin concentration in preterm infants of pre-eclamptic mothers. Arch Dis Child Fetal Neonatal Ed 2000; 83: F13-F16.
44. Sagawa N, Yura S, Itoh H, et al. Possible role of placental leptin in pregnancy: a review. Endocrine 2002; 19: 65-71.
45. Yildiz L, Avoi B, Ingec M. Umbilical cord and maternal blood leptic concentrations in intrauterine growth retardation. Clin Chem Lab Med 2002; 40: 1114-7.
46. Anim-Nyame N, Gamble J, Sooranna SR, Johnson MR, Steer PJ. Microvascular permeability is related to circulating levels of tomour necrosis factor-alpha in pre-eclampsia. Cardiovasc Res 2003; 58: 162-9.
47. Sattar N, Greer IA, Galloway PJ, et al. Lipid and lipoprotein concentrations in pregnancies complicated by intrauteringe growth restriction. J Clin Endocrinol Metab 1999; 84: 128-30.
48. Walace EM, Schneider-Kolsky ME, Edwards A, Baker, L, Jenkin G. Maternal serum activin A levels in association with intrauterine fetal growth restriction. Br J Obstet Gynaecol 2003; 110: 306-10.
49. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-9.
50. Redman CW, Sargent IL. Preeclampsia and the systemic inflammatory response. Semin Nephrol 2004; 24: 565-70.
51. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
52. Powers RW, Roberts JM, Cooper KM, et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 2005; 193: 185-91.
53. Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770-5.
54. McIntyre HD, Serek R, Crane DI, et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab 2000; 85: 1143-50.
55. Haddad B, Abirached F, Louis-Sylvestre C, Le Blond J, Paniel BJ, Zorn JR. Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation. Hum Reprod 1999; 14: 2872-5.
56. Lepage N, Chitayat D, Kingdom J, Huang T. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol 2003; 188: 1354-9.
57. Barkehall-Thomas A, Wilson C, Baker L, ni BM, Wallace EM. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin. Acta Obstet Gynecol Scand 2005; 84: 743-7.
58. Handwerger S, Freemark M. Role of placental lactogen and prolactin in human pregnancy. Adv Exp Med Biol 1987; 219: 399-420.
59. Martin JN Jr, Cowan BD. Biochemical assessment and prediction of gestational well-being. Obstet Gynecol Clin North Am 1990; 17: 81-93.
60. Bersinger NA, Odegard RA. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand 2004; 83: 37-45.
61. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005; 25: 949-53.
62. Gardner MO, Goldenberg RL, Cliver SP, Boots LR, Hoffman HJ. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation. Acta Obstet Gynecol Scand Suppl 1997; 165: 56-8.
63. Markestad T, Bergsjo P, Aakvaag A, et al. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. Acta Obstet Gynecol Scand Suppl 1997; 165: 50-5.
64. Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2001; 72: 85-96.
65. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16: 1677-82.
66. Gilbert GL. 1: Infections in pregnant women. Med J Aust 2002; 176: 229-36.
67. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191: 292-7.
68. Mongelli M, Gardosi J. Fetal growth. Curr Opin Obstet Gynecol 2000; 12: 111-5.
69. Gilbert WM, Danielsen B. Pregnancy outcomes associated with intrauterine growth restriction. Am J Obstet Gynecol 2003; 188: 1596-9.
70. Bukowski R, Gahn D, Denning J. Saade G. Impairment of growth in fetuses destined to deliver preterm. Am J Obstet Gynecol 2001; 185: 463-7.
71. Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: a population study. Pediatrics 1988; 82: 83-90.
72. Weiner CO. Fetal growth deficiency and its evalutation. In: James DK, Steer PJ, Weiner CP, Gonik B Eds, High risk pregnancy. Management options. London: W.B. Saunders Company LTD; 1994; 757-70.
73. Chamberlain G. ABC of antenatal care. Small for gestational age. BMJ 1991; 302:1592-6.
74. Snijders RJ, Sherrod C, Gosden CM, Nicolaides KH. Fetal growth retardation: associated malformations and chromosomal abnormalities. Am J Obstet Gynecol 1993; 168: 547-55.
75. Asmussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res 1975; 36: 579-89.
76. Asmussen I. Ultrastructure of the human placenta at term. Observations on placentas from newborn children of smoking and non-smoking mothers. Acta Obstet Gynecol Scand 1977; 56: 119-26.
77. Asmussen I. Ultrastructure of human umbilical arteries from newborn children of smoking and non-smoking mothers. Acta Pathol Microbiol Immunol Scand [A] 1982; 90: 375-83.
78. Ronco AM, Arguello G, Munoz L, Gras N, Llanos M. Metals content in placentas from moderate cigarette consumers: correlation with newborn birth weight. Biometals 2005; 18: 233-41.
79. Nilsen ST, Sagen N, Kim HC, Bergsjø P. Smoking, hemoglobin levels, and birth weights in normal pregnancies. Am J Obstet Gynecol 1984; 148:752-8.
80. Becroft DM, Thompson JM, Mitchell EA. The epidemiology of placental infarction at term. Placenta 2002; 23: 343-51.
81. Vogt Isaksen C. Maternal smoking, intrauterine growth restriction, and placental apoptosis. Pediatr Dev Pathol. 2004; 7: 433-42.
82. Naeye RL. Abruptio placentae and placenta previa: frequency, perinatal mortality, and cigarette smoking. Obstet Gynecol 1980; 55: 701-4.
83. Mortensen JT, Thulstrup AM, Larsen H, Moller M, Sorensen HT. Smoking, sex of the offspring, and risk of placental abruption, placenta previa, and preeclampsia: a population-based cohort study. Acta Obstet Gynecol Scand 2001; 80: 894-8.
84. Odendaal HJ, van Schie DL, de Jeu RM. Adverse effects of maternal cigarette smoking on preterm labor and abruptio placentae. Int J Gynaecol Obstet 2001; 74: 287-8.
85. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005; 193: 1045-9.
86. Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 2005; 192: 1856-62.
87. Rasmussen S, Irgens LM. The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth 2006; 6: 16-23.
88. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005; 26 (Suppl A): S81-6.
89. Gupta PC, Sreevidya S. Smokeless tobacco use, birth weight, and gestational age: population based, prospective cohort study of 1217 women in Mumbai, India. BMJ 2004; 328: 1538-45.
90. Armant DR, Saunders DE. Exposure of embryonic cells to alcohol: contrasting effects during preimplantation and postimplantation development Semin Perinatol 1996; 20: 127-39.
91. Siler-Khodr TM, Yang Y, Grayson MH, Henderson GI, Lee M, Schenker S. Effect of ethanol on thromboxane and prostacyclin production in the human placenta. Alcohol 2000; 21: 169-80.
92. Yang Q, Witkiewicz BB, Olney RS, et al. A case-control study of maternal alcohol consumption and intrauterine growth retardation. Ann Epidemiol 2001; 11: 497-503.
93. Sokol RJ, aney-Black V, Nordstrom B. Fetal alcohol spectrum disorder. JAMA 2003; 290: 2996-9.
94. Sood B, aney-Black V. Covington C, et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose-response effect. Pediatrics 2001; 108: E34.
95. Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118: 1149-56.
96. Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study, Am J Obstet Gynecol 1995; 172: 19-27.
97. Bluhm EC, Daniels J, Pollock BH, Olshan AF. Maternal use of recreational drugs and neuroblastoma in offspring: a report from the Children's Oncology Group (United States). Cancer Causes Control 2006; 17: 663-9.
98. Savitz DA, Hertz-Picciotto I, Poole C, Olshan AF. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev 2002; 24: 91-101.
99. Fajemirokun-Odudeyi O. Sinha C, Tutty S, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol 2006; 126: 170-5.
100. Fulroth R, Phillips B. Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am J Dis Child 1989; 143: 905-10.
101. Kuhn L, Kline J, Ng S, Levin B. Susser M. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests. Am J Epidemiol 2000; 152: 112-9.
102. Little BB, Snell LM, Klein VR, Gilstrap LC, III. Cocaine abuse during pregnancy: maternal and fetal implications. Obstet Gynecol 1989; 73: 157-60.
103. Bateman DA, Chiriboga CA. Dose-response effect of cocaine on newborn head circumference. Pediatrics 2000; 106: E33.
104. Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 2002; 100: 916-24.
105. Kashiwagi M, Arlettaz R, Lauper U, Zimmermann R, Hebisch G. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 2005; 84: 140-4.
106. Ramirez-Cacho WA, Flores S, Schrader RM, McKay J, Rayburn WF. Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns. J Soc Gynecol Investig 2006; 13: 108-11.
107. Arlettaz R, Kashiwagi M, Das-Kundu S, Fauchere JC, Lang A, Bucher HU. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 2005; 84: 145-50.
108. Burns L, Mattick RP, Lim K, Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007; 102: 264-70.
109. Brodszki J, Hernandez-Andrade E, Gudmundsson S, et al. Can the degree of retrograde diastolic flow in abnormal umbilical artery flow velocity waveforms predict pregnancy outcome? Ultrasound Obstet Gynecol 2002; 19: 229-34.
110. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular, response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-59.
111. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996; 103: 123-9.
112. Ødegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950-1.
113. Long PA, Abell DA, Beischer NA. Fetal growth retardation and pre-eclampsia. BT J Obstet Gynaecol 1980; 87: 13-8.
114. Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003; 101: 575-83.
115. Xiong X, Demianczuk NN, Buekens P, Saunders LD. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000; 183: 148-55.
116. Skomsvoll JF, Ostensen M, Ergens LM, Baste V. Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway. Scand J Rheumatol 1999; 28: 352-6.
117. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol 2004; 103: 1190-3.
118. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101: 6-14.
119. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000; 79: 963-7.
120. Kupferminc MJ, Many A, Bar-Am A, et al. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia.Thrombophilia polymorphisms and intrauterine growth restriction. Br J Obstet Gynaecol 2002; 109: 1373-6.
121. Infante-Rivard C, Rivard GE, Yotov WV, et al. Absence of association of thrombophilia, polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347: 19-25.
122. Hoffman S, Hatch MC. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol 2000; 19: 535-43.
123. Spencer N, Logan S. Social influences on birth weight. J Epidemiol Community Health 2002; 56: 326-7.
124. Spencer N, Bambang S, Logan S, Gill L. Socioeconomic status and birth weight: comparison of an area-based measure with the Registrar General's social class. J Epidemiol Community Health 1999; 53: 495-8.
125. Kramer MS, Goulet L, Lydon J, et al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 2001; 15 (Suppl 2): 104-23.
126. Jacobsen G, Schei B, Hoffman HJ. Psychosocial factors and small-for-gestational-age infants among parous Scandinavian women. Acta Obstet Gynecol Scand Suppl 1997; 165: 14-8.
127. McDonald AD, McDonald JC, Armstrong B, Cherry NM, Nolin AD, Robert D. Prematurity and work in pregnancy. Br J Ind Med 1988; 45: 56-62.
128. Spinillo A. Capuzzo E, Baltaro F, Piazza G, Nicola S, Iasci A. The effect of work activity in pregnancy on the risk of fetal growth retardation. Acta Obstet Gynecol Scand 1996; 75: 531-6.
129. Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy outcome: a meta-analysis. Obstet Gynecol 2000; 95: 623-35.
130. Kalanda BF, Verhoeff FH, Chimsuku L, Harper G, Brabin BJ. Adverse birth outcomes in a malarious area. Epidemiol Infect 2005: 1-8.
131. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Mod Hyg 2003; 97: 30-5.
132. Arechavaleta-Velasco F, Koi H, Strauss JF, III, Parry S. Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? J Reprod Immunol 2002; 55: 113-21.
133. Chan G, Hemmings DG, Yurochko AD, Guilbert LJ. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha. Am J Pathol 2002; 161: 1371-81.
134. Ornoy A, av-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006; 21: 399-409.
135. ACOG practice bulletin. Antepartum fetal surveillance. Number 9, October 1999 (replaces Technical Bulletin Number 188, January 1994). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 68: 175-85.
136. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998; 105: 836-48.
137. Lambert JS, Watts DH, Mofenson L, et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS 2000; 14: 1389-99.
138. Khan NA, Kazzi SN. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 2000; 17: 131-5.
139. Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 2002; 21: 1133-6.
140. Pizzo G, La CM, Conti NM, Guiglia R. Periodontitis and preterm delivery. A review of the literature. Minerva Stomatol 2005; 54: 1-14.
141. Yjong Y, Buekens P, Fraser WD, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: a systematic review. BJOG 2006; 113: 135-43.
142. Bajoria R, Hancock M, Ward S, D'Souza SW, Sooranna SR. Discordant amino acid profiles in monochorionic twins with twin-twin transfusion syndrome. Pediatr Res 2000; 48: 821-8.
143. Taylor MJ, Govender L, Jolly M, Wee L, Fisk NM. Validation of the Quintero staging system for twin-twin transfusion syndrome. Obstet Gynecol 2002; 100: 1257-65.
144. Sooranna SR, Ward S, Bajoria R. Discordant fetal leptin levels in monochorionic twins with chronic midtrimester twin-twin transfusion syndrome. Placenta 2001; 22: 392-8.
145. Bajoria R, Gibson MJ, Ward S, Sooranna SR, Neilson JP, Westwood M. Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome. J Clin Endocrinol Metab 2001; 86: 3150-6.
146. Bajoria R, Sooranna SR, Ward S, D'Souza S, Hancock M. Placental transport rather than maternal concentration of amino acids regulates fetal growth in monochorionic twins: implications for fetal origin hypothesis. Am J Obstet Gynecol 2001; 185: 1239-46.
147. Sooranna SR, Ward S, Bajoria R. Fetal leptin influences birth weight in twins with discordant growth. Pediatr Res 2001; 49: 667-72.
148. Gabbe SG. Intrauterine growth retardation. In: Gabbe SG, Niebyl JR, Simpson JL Eds, Obstetrics. Normal and problem pregnan-cies. New York 1991; 923-44.
149. McElvy SS, Demarini S, Miodovnik M, Khoury JC, Rosenn B, Tsang RC. Fetal weight and progression of diabetic retinopathy. Obstet Gynecol 2001; 97: 587-92.
150. Dawes MG, Grudzinskas JG. Repeated measurement of maternal weight during pregnancy. Is this a useful practice? Br J Obstet Gynaecol 1991; 98: 189-94.
151. Lawton FG, Mason GC, Kelly KA, Ramsay IN, Morewood GA. Poor maternal weight gain between 28 and 32 weeks gestation may predict small-for-gestational-age infants. Br J Obstet Gynaecol 1988; 95: 884-7.
152. Bakketeig LS, Jacobsen G, Hoffman HJ, et al. Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand 1993; 72: 273-9.
153. Ronnenberg AG, Wang X, Xing H, et al. Low preconception body mass index is associated with birth outcome in a prospective cohort of Chinese women. J Nutr 2003; 133: 3449-55.
154. Strauss RS, Dietz WH. Low maternal weight gain in the second or third trimester increases the risk for intrauterine growth retardation. J Nutr 1999; 129: 988-93.
155. Lechtig A, Yarbrough C, Delgado H, Martorell R, Klein RE, Behar M. Effect of moderate maternal malnutrition on the placenta. Am J Obstet Gynecol 1975; 123: 191-201.
156. Neggers YH, Goldenberg RL, Tamura T, Cliver SP, Hoffman HJ. The relationship between maternal dietary intake and infant birthweight. Acta Obstet Gynecol Scand Suppl 1997; 165: 71-5.
157. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000; 71: 1295S-303S.
158. Bendich A. Micronutrients in women's health and immune function. Nutrition 2001; 17: 858-67.
159. Ramakrishnan U, Manjrekar R, Rivera I, Gonzales-Cossio T, Martorell R. Micronutritients and pregnancy outcome: a review of the literature. Nutr Res 1999; 19: 103-59.
160. Treasurb JL, Russell GF. Intrauterine growth and neonatal weight gain in babies of women with anorexia nervosa. BMJ 1988; 296: 1038.
161. Conti J, Abraham S, Taylor A. Eating behavior and pregnancy outcome. J Psychosom Res 1998; 44: 465-77.
162. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93: 2426-30.
163. Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000; 95: 3165-70.
164. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005; 129: 454-63.
165. Agarwal KN, Agarwal DK, Mishra KP. Impact of anaemia prophylaxis in pregnancy on maternal haemoglobin, serum ferritin & birth weight. Indian J Med Res 1991; 94: 277-80.
166. Singla PN, Tyagi M, Kumar A, Dash D, Shankar R. Fetal growth in maternal anaemia. J Trop Pediatr 1997; 48: 89-92.
167. Scholl TO, Hediger ML, Fischer RL, Shearer JW. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992; 55: 985-8.
168. Allen LH. Biological mechanisms that might underlie iron's effects on fetal growth and preterm birth. J Nutr 2001; 131: 581S-9S.
169. Sagen N, Koller O, Haram K. Haemoconcentration in severe preeclampsia. Br J Obstet Gynaecol 1982; 89: 802-5.
170. Little MP, Brocard P, Elliott P, Steer PJ. Hemoglobin concentration in pregnancy and perinatal mortality: a London-based cohort study. Am J Obstet Gynecol 2005; 193: 220-6.
171. Steer P, Alam MA, Wadsworth J, Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ 1995; 310: 489-91.
172. Goodlin RC, Quaife MA, Dirksen JW. The significance, diagnosis, and treatment of maternal hypovolemia as associated with fetal/maternal illness. Semin Perinatol 1981; 5: 163-74.
173. Koller O. The clinical significance of hemodilution during pregnancy. Obstet Gynecol Surv 1982; 37: 649-52.
174. Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr 2000; 71: 1285S-7S.
175. Koller O, Haram K, Sagen N. Maternal hemoglobin concentration and fetal health. In: Bern MD, editor. Hematologic disorders in maternal-fetal medicine. New York: Willy-Liss, Inc; 1990; 31-46.
176. Murphy JF, O'Riordan J, Newcombe RG, Coles EC, Pearson JF. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1986; 1: 992-5.
177. Scanlon KS, Yip R, Schieve LA, Cogswell ME. High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age. Obstet Gynecol 2000; 96: 741-8.
178. Hou J, Cliver SP, Tamura T, Johnston KE, Goldenberg R. Maternal serum ferritin and fetal growth. Obstet Gynecol 2000; 95: 447-52.
179. Entman SS, Richardson LD, Killam AP. Elevated serum ferritin in the altered ferrokinetics of toxemia of pregnancy. Am J Obstet Gynecol 1982; 144: 418-22.
180. Bahna, SL, Bjerkedal T. The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol 1972; 27: 397-406.
181. Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol 2003; 102: 739-52.
182. Goldenberg RL, Cutter GR, Hoffman HJ, Foster JM, Nelson KG, Hauth JC. Intrauterine growth retardation: standards for diagnosis. Am J Obstet Gynecol 1989; 161: 271-7.
183. Moore LG, Shriver M, Bemis L, et al. Maternal adaptation to high-altitude pregnancy: an experiment of nature - a review. Placenta 2004; 25 (Suppl A): S60-S71.
184. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health 1997; 87: 1003-7.
185. Keyes LE, Armaza JF, Niermeyer S, Vargas E, Young DA, Moore LG. Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr Res 2003; 54: 20-5.
186. Churchill D, Bayliss H, Beevers G. Fetal growth restriction. Lancet 2000; 355: 1366-7.
187. Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG. Effect of atenolol on birth weight. Am J Cardiol 1997; 79: 1436-8.
188. Fonager K, Larsen H, Pedersen L, Sorensen HT. Anti-epileptic drugs and intrauterine growth. Acta Neurol Scand 2001; 104: 323-4.
189. Little BB. Immunosuppressant therapy during gestation. Semin Perinatol 1997; 21: 143-8.
190. Ramin SM, Ramin KD, Gilstrap LC. Anticoagulants and thrombolytics during pregnancy. Semin Perinatol 1997; 21: 149-53.
191. Prevot A, Martini S, Guignard JP. In utero exposure to immunosuppressive drugs. Biol Neonate 2002; 81: 73-81.
192. Bryan EM, Kohler HG. The missing umbilical artery. II. Paediatric follow-up. Arch Dis Child 1975; 50: 714-8.
193. Rinehart BK, Terrone DA, Taylor CW, Isler CM, Larmon JE, Roberts WE. Single umbilical artery is associated with an increased incidence of structural and chromosomal anomalies and growth restriction. Am J Perinatol 2000; 17: 224-32.
194. Sepulveda W, Rojas I, Robert JA, Schnapp C, Alcalde JL. Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study. Ultrasound Obstet Gynecol 2003; 21: 564-9.
195. Todros T, Adamson SL, Guiot C, et al. Umbilical cord and fetal growth-a workshop report. Placenta 2002; 23 (Suppl A): S130-S132.
196. Degani S, Leibovich Z, Shapiro I, Gonen R, Ohel G. Early second-trimester low umbilical coiling index predicts
197. Di Naro E, Ghezzi F, Raia L, et al. Umbilical vein blood flow in fetuses with normal and lean umbilical cord. Ultrasound Obstet Gynecol 2001; 17: 224-8.
198. Di Naro E, Ghezzi F, Raio L, Franchi M, D'Addario V. Umbilical cord morphology and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 2001; 96: 150-7.
199. Campbell MK, Østby T, Irgens L. Post term birth: risk factors and outcomes in a ten year cohort study of Norwegian births. Obstet Gynecol 1999; 89: 543-8.
200. Divan MY, Haglund B, Nisell H, Otterblad PO, Westgren M. Fetal and neonatal mortality in postterm pregnancy: the impact of gestational age and fetal growth restriction. Am J Obstet Gynecol 1998; 178: 726-31.
201. Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. Am J Obstet Gynecol 1979; 135: 1086-103.
202. Robinson JS, Moore VM, Owens JA, McMillen IC. Origins of fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2000; 92: 13-9.
203. Rasmussen S. Irgens LK Albrechtsen S, Dalaker K. Predicting preeclampsia in the second pregnancy from low birth weight in the first pregnancy. Obstet Gynecol 2000; 96: 696-700.
204. Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol 1998; 105: 1011-7.
205. Villar J, Merialdi M, Gulmezoglu AM, et al. Characteristics of randomized controlled trials included in systematic reviews of nutritional interventions reporting maternal morbidity, mortality, preterm delivery, intrauterine growth restriction and small for gestational age and birth weight outcomes. J Nutr 2003; 133: 1632S-9S.
206. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316: 1343-7.
207. Smith GD, Whitely E, Gissler K Hemminki E. Birth dimentions of offspring, premature birth, and the mortality of mothers. Lancet 2000; 356: 2066-1067.
208. Vikse BE, Irgens LM, Bostad L, Iversen BM. Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 2006; 17: 837-45.
209. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213-7.
210. Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 2000; 71: 4344S-52S.
211. van Weissenbruch MM, Engelbregt MJ, Vaping MA, Delemarrevan de Waal HA. Fetal nutrition and timing of puberty. Endocr Dev 2005; 8: 15-33.
212. Rees S, Mallard C, Breen S, Stringer M, Cock M, Harding R. Fetal brain injury following prolonged hypoxemia and placental insufficiency: a review. Comp Biochem Physiol A Mol Integr Physiol 1998; 119: 653-60.
213. Manning FA. Intrauterine growth retardation. in: Manning FA, editor. Fetal medicine: Principles and practice. Norwalk Connecticut: Norwalk: Apelton and Lange 1995; 307-93.
214. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340: 1234-8.
215. Ashworth A. Effects of intrauterine growth retardation on mortality and morbidity in infants and young children. Eur J Chn Nutr 1998 52 (Suppl 1): S34-S41.
216. Piper JM, Xenakis EM, McFarland M, Elliott BD, Berkus MD, Langer O. Do growth-retarded premature infants have different rates of peripatal morbidity and mortality than appropriately grown premature infants? Obstet Gynecol 1996; 87: 169-74.
217. Regev RH, Lusky A, Dolfin T, Litmanovitz I, Arnon S, Reichman B. Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. J Pediatr 2003; 143: 186-91.
218. Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004; 191: 481-7.
219. Dashe JS, McIntire DD, Lucas MJ, Leveno KJ. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol 2000; 96: 321-7.
220. Ott WJ. Diagnosis of intrauterine growth restriction: comparison of ultrasound parameters. Am J Perinatol 2002; 19: 133-7.
221. Isaksen CV, Laurini RN, Jacobsen G. Pre-pregnancy risk factors of small-for-gestational-age births and perinatal mortality. Acta Obstet Gynecol Scand Suppl 1997; 165: 44-9.
222. Vik T, Vatten L, Jacobsen G, Bakketeig LS. Prenatal growth in symmetric and asymmetric small-for-gestational-age infants. Early Hum Dev 1997; 48: 167-76.
223. Markestad T, Vik T, Ahlsten G, et al. Small-for-gestational-age (SGA) infants born at term: growth and development during the first year of life. Acta Obstet Gynecol Scand Suppl. 1997; 165: 93-101.
224. Sommerfelt K, Troland K, Ellertsen B, Markestad T. Behavioral problems in low-birthweight preschoolers. Dev Med Child Neurol 1996; 38: 927-40.
225. Elgen I, Sommerfelt K, Markestad T. Population based, controlled study of behavioural problems and psychiatric disorders in low birthweight children at 11 years of age. Arch Dis Child Fetal Neonatal Ed 2002; 87: F128-F132.
226. Fattal-Valevski A, Leitner Y, Geva R, et al. The effect of intrauterine growth restriction on the development and health of children. Nutr Health 2001; 15: 169-75.
227. Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prev Soc Med 1977; 31: 91-5.
228. Marlyn CN, Gale CR, Jespersen S, Sherriff SB. Impaired fetal growth and atherosclerosis of carotid and peripheral arteries. Lancet 1998; 352: 173-8.
229. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298: 564-7.
230. Barker DJ, Martyn CN, Osmond C, et al. Growth in utero and senim cholesterol concentrations in adult life. BMJ 1993; 307: 1524-7.
231. Barker DJ, Gluckman PD. Godfrey Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-41.
232. Fall CH. The fetal and early life origins of adult disease. Indian Pediatr 2003; 40: 480-502.
233. Ong M Dunger DB. Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab 2002; 16: 191-207.
234. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353: 1789-92.
235. Vanhala M. Childhood weight and metabolic syndrome in adults. Ann Med 1999; 31: 236-9.
236. Vatten LJ, Machle DO, Lund Nilsen TI, et al. Birth weight as a predictor of breast cancer: a case-control study in Norway. Br J Cancer 2002; 86: 89-91.
237. Lu MC, Tache V, Alexander GR, Kotelchuck M, Halfon N. Preventing low birth weight: is prenatal care the answer? J Matern Fetal Neonatal Med 2003; 13: 362-80.
238. Baschat AA, Weiner CP. Umbilical artery doppler screening for detection of the small fetus in need of antepartum surveillance. Am J Obstet Gynecol 2000; 182: 154-8.
239. Burke G, Stuart B. Crowley P, Scanaill SN, Drumm, J. Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition? BMJ 1990; 300: 1044-5.
240. Visser GH, Huisman A, Saathof PW, Sinnige HA. Early fetal growth retardation: obstetric background and recurrence rate. Obstet Gynecol 1986; 67: 40-3.
241. Bakketeig LS, Bjerkedal T, Hoffman HJ. Small-for-gestational age births in successive pregnancy outcomes: results from a longitudinal study of births in Norway. Early Hum Dev 1986; 14: 187-200.